Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on.
How labels work
Federal · 119th Congress
HR5646Restoring Safeguards for Dangerous Abortion Drugs Act
Direction
Abortionmedication abortionAI label
↓Restricts abortion accessmodel confidence 95%
Requires HHS to reinstate the stricter 2011 REMS for mifepristone (with in-person dispensing and other limits) and bans its importation, so less medication-abortion access.
approve a risk evaluation and mitigation strategy for the covered medication that is identical to the risk evaluation and mitigation strategy for such covered medication that was approved by such Secretary in June 2011.
✓ Quote verified word for word in the bill text
Abortionprovider clinic regulationAI label
↓Restricts abortion accessmodel confidence 90%
Mandates a specific REMS for mifepristone that cannot be altered and adds federal tort liability for entities involved in its distribution, so more regulation of medication-abortion providers and pharmacies.
shall require a risk evaluation and mitigation strategy pursuant to such section 505-1 for the covered medication;
✓ Quote verified word for word in the bill text
Abortionfunding insuranceAI label
=No change to abortion accessmodel confidence 0%
No provision in the bill addresses public funding, insurance coverage, or related issues for abortion.
To require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.
✓ Quote verified word for word in the bill text
AbortionotherAI label
↓Restricts abortion accessmodel confidence 85%
Creates a federal private right of action allowing civil suits for harms from mifepristone use against importers/transporters, increasing liability exposure for medication abortion distribution.
A covered entity shall be liable in accordance with this section to any individual who suffers bodily injury or harm to mental health ... that is attributable, in whole or in part, to the individual's use of a covered medication
⚠ Quote could not be matched to the bill text: treat this label with caution
Abortionbans gestational limitsAI label
=No change to abortion accessmodel confidence 0%
No provision in the bill addresses gestational limits or bans on abortion procedures.
This Act may be cited as the ``Restoring Safeguards for Dangerous Abortion Drugs Act''.
✓ Quote verified word for word in the bill text
Introduced (completed)
Committee
Passed one chamber
Passed both
President
Law
Stage: Committee · step 2 of 6
Last action
2025-09-30: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Why the model tagged it this way: The bill substantively addresses abortion by reinstating a stricter REMS for mifepristone (a medication used for abortion), banning its importation, imposing federal tort liability on distributors, and prohibiting changes to the REMS; these provisions restrict access and increase regulation of medication abortion. No provisions address transgender issues, firearms, or immigration enforcement. Neutral tags were included only where the bill text touches related abortion categories without changing the axis.
Related bills
HR10600Abortion is Health Care Everywhere Act of 2026↑Expands abortion access↑Expands abortion access Committee
S5565Abortion is Health Care Everywhere Act of 2026↑Expands abortion access↑Expands abortion access Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-09-30
House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.